Cargando…
CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells
RANK/RANKL facilitates migration/invasion via epithelial-mesenchymal transition (EMT) in certain malignant tumors. The relationship and mechanism between RANK/RANKL and EMT in endometrial cancer (EC) cells, however, remain unclear. In this study, we firstly showed that RANK/RANKL activation was corr...
Autores principales: | Liu, Yao, Wang, Jing, Ni, Ting, Wang, Lihua, Wang, Yudong, Sun, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041907/ https://www.ncbi.nlm.nih.gov/pubmed/27015366 http://dx.doi.org/10.18632/oncotarget.8291 |
Ejemplares similares
-
Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer
por: Wang, Jing, et al.
Publicado: (2015) -
Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway
por: Shao, Minghai, et al.
Publicado: (2022) -
CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition
por: Fan, Tao, et al.
Publicado: (2022) -
Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma
por: Chen, Xueran, et al.
Publicado: (2017) -
Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)